BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 6498086)

  • 1. Cellular uptake of clindamycin and lincomycin.
    Easmon CS; Crane JP
    Br J Exp Pathol; 1984 Dec; 65(6):725-30. PubMed ID: 6498086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different kinetic of enzymatic inactivation of lincomycin and clindamycin in Staphylococcus aureus.
    Barcs I
    J Chemother; 1993 Aug; 5(4):215-22. PubMed ID: 8229148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [In-vitro activity of clindamycin and lincomycin in the presence of Staphylococcus aureus].
    Wiedemann B
    Fortschr Med; 1984 Jun; 102(21):603-4. PubMed ID: 6469163
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sensitivity of hospital strains of Staphylococcus aureus to lincomycin and clindamycin].
    Jakubicz P; Dzierzanowska D
    Pol Tyg Lek; 1980 Feb; 35(8):269-71. PubMed ID: 7360703
    [No Abstract]   [Full Text] [Related]  

  • 5. Clindamycin as an anti-staphylococcal agent--indications and limitations.
    Hedström SA
    Scand J Infect Dis Suppl; 1984; 43():62-6. PubMed ID: 6598522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial activity of clindamycin and lincomycin in broth, serum, and in combination with polymorphonuclear leukocytes against Staphylococcus aureus and Staphylococcus epidermidis].
    Bassler M; Just HM; Richter A; Zeller H; Daschner F
    Infection; 1984; 12(4):280-5. PubMed ID: 6490174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of antibiotics in chronic granulomatous disease leukocytes.
    Jacobs RF; Wilson CB
    Pediatr Res; 1983 Nov; 17(11):916-9. PubMed ID: 6646904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus.
    Leclercq R; Carlier C; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1985 Sep; 28(3):421-4. PubMed ID: 3907492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial kinetics of drug action against gram-positive and gram-negative organisms. III: Effect of lincomycin and clindamycin combinations on Staphylococcus aureus and Escherichia coli.
    Heman-Ackah SM
    J Pharm Sci; 1975 Oct; 64(10):1621-6. PubMed ID: 1102659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new types of resistance to lincomycin in pathogenic staphylococci from animals.
    Devriese LA
    Ann Microbiol (Paris); 1980; 131B(3):261-6. PubMed ID: 7469255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Susceptibility of bacteria to serum lysis or phagocytosis following growth in subinhibitory levels of lincosaminide or spectinomycin related antibiotics.
    Cialdella JI; Vavra JJ; Marshall VP
    J Antibiot (Tokyo); 1986 Jul; 39(7):978-84. PubMed ID: 2944862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lincomycin, clindamycin and their applications.
    Spízek J; Rezanka T
    Appl Microbiol Biotechnol; 2004 May; 64(4):455-64. PubMed ID: 14762701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of phagocyte membrane stimulation on antibiotic uptake and intracellular bactericidal activity.
    Steinberg TH; Hand WL
    Antimicrob Agents Chemother; 1987 Apr; 31(4):660-2. PubMed ID: 3606071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of cloxacillin on staphylococci phagocytosed by bovine neutrophils.
    Craven N; Anderson JC
    Res Vet Sci; 1980 Jul; 29(1):57-62. PubMed ID: 7455355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro efficacy of several antibiotics against intracellular S. aureus in chronic granulomatous disease.
    Zimmerli W; Lew PD; Suter S; Wyss M; Waldvogel FA
    Helv Paediatr Acta; 1983 Mar; 38(1):51-61. PubMed ID: 6862995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The rate of inducible clindamycin resistance and susceptibilities to other antimicrobial agents in staphylococci].
    Oğuz VA; Yapar N; Sezak N; Cavuş SA; Kurutepe S; Peksel H; Cakir N; Yüce A
    Mikrobiyol Bul; 2009 Jan; 43(1):37-44. PubMed ID: 19334378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions between antibiotics and human neutrophils in the killing of staphylococci.
    Root RK; Isturiz R; Molavi A; Metcalf JA; Malech HL
    J Clin Invest; 1981 Jan; 67(1):247-59. PubMed ID: 7451652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical microbiology of lincomycin antibiotics].
    Modde H
    Fortschr Med; 1973 May; 91(15):677-82. PubMed ID: 4145081
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a method for measurement of intracellular killing of Staphylococcus aureus in human neutrophil granulocytes.
    Nielsen SL; Black FT; Storgaard M; Obel N
    APMIS; 1995 Jun; 103(6):460-8. PubMed ID: 7546649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
    Sula L; Sulová J
    Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.